100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
1887057-05-7Docetaxel EP Impurity A
● In Stock
| Catalogue No.: | VL49007 |
|---|---|
| CAS No.: | 1887057-05-7 |
| Mol. Formula: | C41H55NO14 |
| Mol. Weight: | 785.88 g/mol |
Additional information on CAS 1887057-05-7
Parent drug
Docetaxel TrihydrateIUPAC Name
5β, 20-Epoxy-1, 7β, 10β-trihydroxy-9-oxotax-11-ene-2α, 4, 13α-triyl 4-acetate 13-[(2R, 3S)-3-[[(1, 1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenyl propanoate] 2-[(2E)-2-methylbut-2-enoate]Synonyms
2-Debenzoxyl 2-pentenoyl docetaxelDescription
Docetaxel EP Impurity A (CAS No.: 1887057-05-7) or 2-Debenzoxyl 2-pentenoyl docetaxel is an adulteration of Docetaxel which is a member of the taxoid class of antineoplastic agents. It depicts its action by bettering the microtubule assembly and by stabilizing microtubules by preventing their depolymerization and thereby disrupting normal cell division.References
Vasu Dev, R., et al. “Isolation and Characterization of Impurities in Docetaxel.†Journal of Pharmaceutical and Biomedical Analysis, vol. 40, no. 3, Feb. 2006, pp. 614–22, https://doi.org/10.1016/j.jpba.2005.10.037.?Fulton, Bret, and Caroline M. Spencer. “Docetaxel.†Drugs, vol. 51, no. 6, June 1996, pp. 1075–92, https://doi.org/10.2165/00003495-199651060-00011.Request a Quote
"*" indicates required fields
Other products related to Docetaxel Trihydrate impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
Docetaxel / Docetaxel Trihydrate
CAS No. 148408-66-6
Cat No. VE0027758
